Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
42 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Upsher-Smith Laboratories, Inc. (Upsher-Smith) is a pharmaceutical company that develops, manufactures and distributes consumer and CNS products. The companys consumer products include restoring body lotion, foot cream, moisturizing body lotion, hydrating body cream, vitamin D3, folic acid, vitamins B6 and B12, and dietary supplement. It offers CNS products such as carbamazepine tablets, divalproex sodium delayed-release tablets, lamotrigine tablets, phenytoin sodium extended-release capsules, topiramate capsules and valproic acid capsules. Upsher-Smith provides products for therapeutic areas such as central nervous system disorders and specialty indications.

Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company&l

  
Source:
Document ID
GDPH127106D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Upsher-Smith Laboratories, Inc., Pharmaceuticals &Healthcare, Deal Details1127
  Asset Purchase111
    Proximagen Acquires Two CNS Drug Development Programmes From GlaxoSmithKline112
  Partnerships131
    Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company131
    Proximagen Enters into Co-Development Agreement with Saniona141
    MRC Technology Enters into Co-Development Agreement with Proximagen151
    Upsher-Smith Labs Enters Into Development Agreement With Lundbeck161
    Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma172
    H. Lundbeck Enters Into Co-Development Agreement With Proximagen191
    Novo Nordisk Enters Into Co-Marketing Agreement With Upsher-Smith Labs201
    Proximagen Neuroscience Enters Into A Collaboration With The National Institutes of Health212
  Licensing Agreements231
    F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen231
    Ligand Pharma Enters Into Licensing Agreement With Proximagen Group241
    Proximagen Group Enters Into Licensing Agreement With BrainCells252
    Upsher-Smith Labs Enters Into Licensing Agreement With Ikano Therapeutics271
    Upsher-Smith Labs Enters Into Licensing Agreement With Proximagen282
  Asset Transactions301
    Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs302
  Acquisition321
    Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million323
    Upsher-Smith Labs Acquires Additional 1.22% Stake In Proximagen351
    Proximagen Neuroscience Acquires Minster Pharma362
Upsher-Smith Laboratories, Inc. - Key Competitors381
Key Employees391
Locations And Subsidiaries402
  Head Office401
  Other Locations &Subsidiaries402
Appendix421
  Methodology421
  About GlobalData421
  Contact Us421
  Disclaimer421

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Upsher-Smith-Laboratories-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6698>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Upsher-Smith Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Upsher-Smith-Laboratories-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6698>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research